Envoy Medical Valuation Multiples

Envoy Medical is valued at $50M as of October 2026, a 132.1x revenue multiple. In the last 12 months, Envoy Medical revenue was $235K.

Envoy Medical Overview

About Envoy Medical

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.


Founded

1995

HQ

United States

Employees

42

Financials (LTM)

Revenue: $235K
Net Income: ($26M)

EV

$31M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Envoy Medical Financials

Envoy Medical reported last 12-month revenue of $235K.

In the same LTM period, Envoy Medical generated ($829K) in gross profit and had net loss of ($26M).

Revenue (LTM)


Envoy Medical P&L

In the most recent fiscal year, Envoy Medical reported revenue of $241K and EBITDA of ($22M).

Envoy Medical is unprofitable as of last fiscal year, with gross margin of (263%), EBITDA margin of (9072%), and net margin of (9857%).

See analyst estimates for Envoy Medical
LTMLast FY202320242025202620272028
Revenue$235K$241K$316K$225K$241K
Gross Profit($829K)($633K)($473K)($517K)($633K)
Gross Margin(353%)(263%)(150%)(230%)(263%)
EBITDA-($22M)($30M)($20M)($22M)
EBITDA Margin-(9072%)(9427%)(8803%)(9072%)
EBIT Margin(9879%)(9241%)(5810%)(8558%)(9241%)
Net Profit($26M)($24M)($30M)($21M)($24M)
Net Margin(11184%)(9857%)(9469%)(9242%)(9857%)
Net Debt-($4M)---

Financial data powered by Morningstar, Inc.

Envoy Medical Stock Performance

Envoy Medical has current market cap of $50M, and enterprise value of $31M.

Market Cap Evolution


Envoy Medical's stock price is $0.64.

Envoy Medical share price decreased by 5.5% in the last 30 days, and by 19.9% in the last year.

Envoy Medical has an EPS (earnings per share) of $-0.31.

See more trading valuation data for Envoy Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$31M$50M2.3%-5.5%-3.6%-19.9%$-0.31

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Envoy Medical Valuation Multiples

Envoy Medical trades at 132.1x EV/Revenue multiple, and (1.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for Envoy Medical

EV / Revenue (LTM)


Envoy Medical Financial Valuation Multiples

As of October 16, 2026, Envoy Medical has market cap of $50M and EV of $31M.

Envoy Medical has a P/E ratio of (1.9x).

LTMLast FY202320242025202620272028
EV/Revenue132.1x128.7x98.2x137.9x128.7x
EV/EBITDA-(1.4x)(1.0x)(1.6x)(1.4x)
EV/EBIT(1.3x)(1.4x)(1.7x)(1.6x)(1.4x)
EV/Gross Profit(37.4x)(49.0x)(65.6x)(60.0x)(49.0x)
P/E(1.9x)(2.1x)(1.7x)(2.4x)(2.1x)
EV/FCF-(1.7x)(1.8x)(1.6x)(1.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Envoy Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Envoy Medical Margins & Growth Rates

Envoy Medical decreased revenue by 3% but EBITDA grew by 6% in the last fiscal year.

In the most recent fiscal year, Envoy Medical reported gross margin of (263%), EBITDA margin of (9072%), and net margin of (9857%).

See estimated margins and future growth rates for Envoy Medical

Envoy Medical Margins

Last FY202420252026202720282029
Gross Margin(263%)(230%)(263%)(377%)
EBITDA Margin(9072%)(8803%)(9072%)(9964%)
EBIT Margin(9241%)(8558%)(9241%)(10053%)
Net Margin(9857%)(9242%)(9857%)(11545%)
FCF Margin(7627%)(8413%)(7627%)(12429%)

Envoy Medical Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(3%)(29%)7%(3%)
Gross Profit Growth39%9%22%39%
EBITDA Growth6%(34%)10%6%
EBIT Growth5%5%16%5%
Net Profit Growth13%(31%)14%13%
FCF Growth58%10%(3%)58%

Data powered by FactSet, Inc. and Morningstar, Inc.

Envoy Medical Operational KPIs

Envoy Medical's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.5M for the same period.

Envoy Medical's Rule of 40 is (9967%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Envoy Medical's Rule of X is (9972%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Envoy Medical
LTMLast FY202320242025202620272028
Rule of 40-(9967%)---
Bessemer Rule of X-(9972%)---
Revenue per Employee-$0.0M---
Opex per Employee-$0.5M---
S&M Expenses to Revenue368%506%527%771%506%
G&A Expenses to Revenue3316%3291%2299%3034%3291%
R&D Expenses to Revenue5755%5181%2834%4524%5181%
Opex to Revenue-8978%5660%8328%8978%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Envoy Medical Competitors

Envoy Medical competitors include Spectral AI, FluoGuide, BATM Advanced Communications, Renalytix, Myomo, K Pharma, Zepp Health, Svas Biosana, Theraclion and Ceretas.

Most Envoy Medical public comparables operate across Medical Devices, DeepTech and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Spectral AI$20M($5M)2.6x2.8x(11.4x)-
FluoGuide-($7M)-3623.5x(7.1x)(5.7x)
BATM Advanced Communications$123M$18M0.3x0.4x2.1x-
Renalytix$3M($21M)16.0x16.0x(2.3x)-
Myomo$41M($13M)1.4x1.3x(4.6x)(8.2x)
K Pharma-($6M)--(7.7x)-
Zepp Health$259M($27M)0.9x0.8x(8.3x)(11.1x)
Svas Biosana$158M$21M0.7x0.7x5.1x5.1x

This data is available for Pro users. Sign up to see all Envoy Medical competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Envoy Medical

When was Envoy Medical founded?Envoy Medical was founded in 1995.
Where is Envoy Medical headquartered?Envoy Medical is headquartered in United States.
How many employees does Envoy Medical have?As of today, Envoy Medical has over 42 employees.
Who is the CEO of Envoy Medical?Envoy Medical's CEO is Brent T. Lucas.
Is Envoy Medical publicly listed?Yes, Envoy Medical is a public company listed on Nasdaq.
What is the stock symbol of Envoy Medical?Envoy Medical trades under COCH ticker.
When did Envoy Medical go public?Envoy Medical went public in 2023.
Who are competitors of Envoy Medical?Envoy Medical main competitors include Spectral AI, FluoGuide, BATM Advanced Communications, Renalytix, Myomo, K Pharma, Zepp Health, Svas Biosana, Theraclion, Ceretas.
What is the current market cap of Envoy Medical?Envoy Medical's current market cap is $50M.
What is the current revenue of Envoy Medical?Envoy Medical's last 12 months revenue is $235K.
What is the current revenue growth of Envoy Medical?Envoy Medical revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Envoy Medical?Current revenue multiple of Envoy Medical is 132.1x.
Is Envoy Medical profitable?No, Envoy Medical is not profitable.
What is the current net income of Envoy Medical?Envoy Medical's last 12 months net income is ($26M).
How many companies Envoy Medical has acquired to date?Envoy Medical hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Envoy Medical has invested to date?Envoy Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Envoy Medical

Lists including Envoy Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial